Johnson & Johnson vs Summit Therapeutics Inc.
JNJ vs SMMT — side-by-side comparison from reported financials. JNJ leads 4, SMMT leads 1 of 5 comparable metrics.
Johnson & Johnson
JNJ · Healthcare
$261.79+2.07%Mixed
Summit Therapeutics Inc.
SMMT · Healthcare
$17.55+2.21%Strained
| Metric | JNJ | SMMT |
|---|---|---|
| Price | $261.79 | $17.55 |
| Market cap | $631B | $14.0B |
| Revenue (TTM) | $97.9B | — |
| Revenue growth | +5.6% | — |
| Net margin | 21.5% | — |
| Free cash flow | $22.2B | -$932M |
| Net cash (debt) | ($27.8B) | $670M |
| 1-year price return | +37.0% | -22.5% |
| P/E | 29.9 | — |
| P/E vs own history (cheap-side %) | 16% | — |
| Dividend yield | 2.00% | — |
| Return on equity | 26% | -169% |
| CV checks passed | 10 of 11 | 3 of 11 |
| Employees | 140,800 | 265 |
Full résumé-style profiles: JNJ CV · SMMT CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.